These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31568536)
1. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries. Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536 [TBL] [Abstract][Full Text] [Related]
2. The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications. Roberts KB; Soulos PR; Herrin J; Yu JB; Long JB; Dostaler E; Gross CP Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1186-92. PubMed ID: 23182396 [TBL] [Abstract][Full Text] [Related]
3. Hypofractionated radiation in older women with breast cancer. Wallace AS; Keene KS; Williams CP; Jackson BE; Pisu M; Rocque GB Breast J; 2019 Nov; 25(6):1206-1213. PubMed ID: 31359556 [TBL] [Abstract][Full Text] [Related]
4. Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation. Torres MA; Gogineni K; Howard DH J Natl Cancer Inst; 2020 Mar; 112(3):314-317. PubMed ID: 31647560 [TBL] [Abstract][Full Text] [Related]
5. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform. Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179 [TBL] [Abstract][Full Text] [Related]
6. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. Smith BD; Pan IW; Shih YC; Smith GL; Harris JR; Punglia R; Pierce LJ; Jagsi R; Hayman JA; Giordano SH; Buchholz TA J Natl Cancer Inst; 2011 May; 103(10):798-809. PubMed ID: 21525437 [TBL] [Abstract][Full Text] [Related]
7. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis. Sher DJ; Neville BA; Chen AB; Schrag D Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483 [TBL] [Abstract][Full Text] [Related]
8. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011. Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334 [TBL] [Abstract][Full Text] [Related]
9. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials. Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365 [TBL] [Abstract][Full Text] [Related]
10. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer. Sen S; Wang SY; Soulos PR; Frick KD; Long JB; Roberts KB; Yu JB; Evans SB; Chagpar AB; Gross CP J Natl Cancer Inst; 2014 Mar; 106(3):dju008. PubMed ID: 24598714 [TBL] [Abstract][Full Text] [Related]
11. Out-of-Pocket Cost Modeling of Adjuvant Antiestrogen and Radiation Therapy After Lumpectomy for Early-Stage Breast Cancer Across Medicaid and Medicare Plans. Wu VS; Khlopin M; Chadha M; Smith-Graziani DJ; Jagsi R; McClelland S Int J Radiat Oncol Biol Phys; 2024 Aug; 119(5):1379-1385. PubMed ID: 38432284 [TBL] [Abstract][Full Text] [Related]
12. Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009. Yeboa DN; Xu X; Jones BA; Soulos P; Gross C; Yu JB Am J Clin Oncol; 2016 Dec; 39(6):568-574. PubMed ID: 24879475 [TBL] [Abstract][Full Text] [Related]
13. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer. Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697 [TBL] [Abstract][Full Text] [Related]
14. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage. Karpf D; Sakka M; Metzger M; Grabenbauer GG Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165 [TBL] [Abstract][Full Text] [Related]
15. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. Yu JB; Soulos PR; Herrin J; Cramer LD; Potosky AL; Roberts KB; Gross CP J Natl Cancer Inst; 2013 Jan; 105(1):25-32. PubMed ID: 23243199 [TBL] [Abstract][Full Text] [Related]
16. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470 [TBL] [Abstract][Full Text] [Related]
17. Cost and Cost-Effectiveness of Image Guided Partial Breast Irradiation in Comparison to Hypofractionated Whole Breast Irradiation. Shah C; Ward MC; Tendulkar RD; Cherian S; Vicini F; Singer ME Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):397-402. PubMed ID: 30253236 [TBL] [Abstract][Full Text] [Related]
18. Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further? Mast ME; van Kempen-Harteveld L; Heijenbrok MW; Kalidien Y; Rozema H; Jansen WP; Petoukhova AL; Struikmans H Radiother Oncol; 2013 Aug; 108(2):248-53. PubMed ID: 24044804 [TBL] [Abstract][Full Text] [Related]
19. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery. Mansouri S; Naim A; Glaria L; Marsiglia H Asian Pac J Cancer Prev; 2014; 15(11):4727-32. PubMed ID: 24969911 [TBL] [Abstract][Full Text] [Related]
20. Evaluating radiotherapy options in breast cancer: does intraoperative radiotherapy represent the most cost-efficacious option? Shah C; Badiyan S; Khwaja S; Shah H; Chitalia A; Nanavati A; Kundu N; Vaka V; Lanni TB; Vicini FA Clin Breast Cancer; 2014 Apr; 14(2):141-6. PubMed ID: 24291378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]